Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.47 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.47 |
| ▸ | ESR1 | P03372 | 3/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | XDH | P47989 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | CNR1 | P21554 | 2/20 | 0.38 |
| ▸ | CNR2 | P34972 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4045452 | 0.83 | GABRA1 (0.48) | GABRA1GABRB2ESR1ESR2POLB | |
| SCHEMBL5931901 | 0.83 | GABRA1 (0.48) | GABRA1GABRB2ESR1ESR2POLB | |
| SCHEMBL11261841 | 0.81 | GABRA1 (0.47) | GABRA1GABRB2ESR1ESR2POLB | |
| SCHEMBL9721939 | 0.79 | GABRA1 (0.45) | GABRA1GABRB2ESR1ESR2POLB | |
| SCHEMBL5849191 | 0.79 | GABRA1 (0.45) | GABRA1GABRB2ESR1ESR2POLB | |
| SCHEMBL3473236 | 0.79 | GABRA1 (0.45) | GABRA1GABRB2ESR1ESR2POLB | |
| SCHEMBL5931905 | 0.77 | GABRA1 (0.48) | GABRA1GABRB2ESR1ESR2POLB | |
| SCHEMBL29837102 | 0.77 | GABRA1 (0.48) | GABRA1GABRB2ESR1ESR2POLB | |
| SCHEMBL11063628 | 0.77 | GABRA1 (0.44) | GABRA1GABRB2ESR1ESR2POLB | |
| SCHEMBL27861509 | 0.76 | GABRA1 (0.42) | GABRA1GABRB2ESR1ESR2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101528668-B | Macromolecular amine-phenolic antioxidant compositions, its production technology and use | SI GROUP INC. (US) | 2016-04-20 | — | — | CN | disclosed |
| CN-101528668-A | Macromolecular amine-phenolic antioxidant compositions, process technology thereof, and uses thereof | ALBEMARLE CORP (US) | 2009-09-09 | — | — | CN | disclosed |
| US-20090054698-A1 | Granular Polymer Additives and Their Preparation | ALBEMARLE CORPORATION (US) | 2009-02-26 | — | — | US | disclosed |
| US-7425290-B2 | Compaction; dry granulation; uniform mixture; steric hindrance phenolic compound and polymer; forming paste; compression, shaping; drying | ALBEMARLE CORPORATION (US) | 2008-09-16 | — | — | US | disclosed |
| US-20050009725-A1 | Compaction; dry granulation; uniform mixture; steric hindrance phenolic compound and polymer; forming paste; compression, shaping; drying | ALBEMARLE CORPORATION | 2005-01-13 | — | — | US | disclosed |
| US-6821456-B2 | STERICALLY-HINDERED PHENOLIC COMPOUND MIXTURE; INTERBONDS IN SITU WITH DESOLVATED SURFACES | ALBEMARLE CORPORATION | 2004-11-23 | — | — | US | disclosed |
| EP-1363972-A1 | GRANULAR POLYMER ADDITIVES AND THEIR PREPARATION | ALBEMARLE CORPORATION (US) | 2003-11-26 | — | — | EP | disclosed |
| US-20030193041-A1 | Sterically-hindered phenolic compound mixture; interbonds in situ with desolvated surfaces | ALBEMARLE CORPORATION | 2003-10-16 | — | — | US | disclosed |
| WO-2002068523-A1 | GRANULAR POLYMER ADDITIVES AND THEIR PREPARATION | ALBEMARLE CORPORATION (US) | 2002-09-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054698-A1 | Granular Polymer Additives and Their Preparation | GRN, C9, COG4 | GABRA1 2752/4885GABRB2 2450/4885ESR1 2035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.